1. American Diabetes Associatation. 8. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2018. Diabetes Care. 2018; 41:Suppl 1. S73–S85.
2. IRF. van Berlo-van de Laar IRF, Vermeij CG, Doorenbos CJ. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements. Journal of Clinical Pharmacy and Therapeutics. 2011; 36:376–382.
Article
3. Salpeter SR, Greyber E, Pasternak GA, et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010; 14(4):CD002967.
Article
4. Lalau JD, Andrejak M, Morinier P, et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol. 1989; 27(6):285–288.
5. Bailey CJ, Wilcock C, Day C. Effect of metformin on glucose metabolism in the splanchnic bed. Br J Pharmacol. 1992; 105(4):1009.
Article
6. Vecchio S, Giampreti A, Petrolini VM, et al. Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol(Phila). 2014; 52(2):129–135.
Article
7. Sirtori CR, Pasik C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res. 1994; 30(3):187.
Article
8. Sprensen PN. Transitory blindness during ethanol and phenethylbiguianide induced lactic acidosis in a subject with diabetes mellitus. A case report. Acta Ophthalmol (Copenh). 1977; 55(2):177–182.
9. Cicarran S, Rodriquez ML, Pousa M, et al. Transient vision loss in a patient with severe metformin-associated lactic acidosis. QJM. 2012; 105(8):781–783.
Article
10. Deutsch G. Transient blindness associated with severe diabetic ketoacidosis. Minn Med. 1981; 64(4):401.
11. Colin F, Marin M, Stephen B, et al. Reversible blindness associated with alcoholic ketoacidosis: pseudomethanol intoxication. J Emerg Med. 1998; 16(4):597–599.
Article
12. Kreshak AA, Clark RF. Transient vision loss in a patient with metformin associated lactic acidosis. Am J Emerg Med. 2010; 28(9):1059.e5–1059.e7.
13. Osborne NN, Casson RJ, Wood JP, et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004; 23(1):91–147.
Article